Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Citi
McKesson
QuintilesIMS
Farmers Insurance
Healthtrust

Generated: May 24, 2019

DrugPatentWatch Database Preview

Prinston Inc Company Profile

« Back to Dashboard

What is the competitive landscape for PRINSTON INC, and what generic and branded alternatives to PRINSTON INC drugs are available?

PRINSTON INC has fifty-six approved drugs.

There is one tentative approval on PRINSTON INC drugs.

Summary for Prinston Inc
US Patents:0
Tradenames:48
Ingredients:48
NDAs:56

Drugs and US Patents for Prinston Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Prinston Inc LOSARTAN POTASSIUM losartan potassium TABLET;ORAL 091497-001 Jun 6, 2011 AB RX No No ➤ Sign Up ➤ Sign Up
Prinston Inc LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; losartan potassium TABLET;ORAL 204901-002 Nov 6, 2017 AB RX No No ➤ Sign Up ➤ Sign Up
Prinston Inc CLOPIDOGREL BISULFATE clopidogrel bisulfate TABLET;ORAL 206376-001 May 7, 2018 AB RX No No ➤ Sign Up ➤ Sign Up
Prinston Inc LEVETIRACETAM levetiracetam TABLET, EXTENDED RELEASE;ORAL 202533-002 Jul 20, 2012 AB RX No No ➤ Sign Up ➤ Sign Up
Prinston Inc METFORMIN HYDROCHLORIDE metformin hydrochloride TABLET, EXTENDED RELEASE;ORAL 208880-001 Sep 10, 2018 AB1 RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
Harvard Business School
Express Scripts
Deloitte
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.